Nefense, a company specializing in advanced clinical hygiene and airway health solutions, has officially launched its Hypochlorous Acid (HOCl) nasal spray line. The product expansion introduces an age-specific approach to respiratory hygiene, offering tailored formulations for adults, children, and infants. This move aims to address the growing need for safe, effective nasal care that supports natural defenses without relying on harsh chemicals or steroids.
The flagship product, Hyponasal spray, delivers a gentle, clinical-grade biocleanse that flushes irritants from the nasal passages, provides immediate soothing relief, and supports the body's natural respiratory defenses. Powered by hypochlorous acid, the formulations offer broad-spectrum antimicrobial and anti-inflammatory action. According to the company, this helps neutralize bacteria and viruses, prevent upper respiratory infections, and combat seasonal allergies. The product line is designed for daily use as part of a comprehensive airway hygiene routine.
Hypochlorous acid is a naturally occurring substance produced by the body's immune system to fight infection and inflammation. By incorporating it into a nasal spray, Nefense aims to provide a safe alternative to traditional nasal treatments that may contain steroids or other active ingredients with potential side effects. The company notes that the product is suitable for all ages, with specific formulations adjusted for the delicate nasal tissues of children and infants.
Nefense has long been involved in developing science-driven health and hygiene products, working in collaboration with doctors and ENT specialists. Their product portfolio already includes XyloClean, a xylitol-based nasal spray designed to moisturize and rebalance nasal passages. The new HOCl line represents a significant step forward in the company's mission to bridge the gap between daily hygiene and overall wellness.
The announcement highlights the importance of airway health in overall well-being, especially in the context of rising concerns about respiratory infections and environmental irritants. By offering age-specific solutions, Nefense is addressing a critical gap in the market for safe, effective nasal care products that can be used by the entire family. The company's commitment to clinical collaboration and scientific innovation underpins the development of these new products.
For more details on the product line and its availability, the full announcement can be viewed here. Nefense continues to expand its reach, with many clinics and practices nationwide offering in-store purchases of its nasal spray family, including the XyloClean product.
